- Previous Close
0.5000 - Open
0.5380 - Bid 0.6530 x --
- Ask 0.6530 x --
- Day's Range
0.5300 - 0.9850 - 52 Week Range
0.0509 - 5.6000 - Volume
105,760,532 - Avg. Volume
3,483,784 - Market Cap (intraday)
548.316M - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.00
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
qlinea.comRecent News: QLINEA.ST
View MorePerformance Overview: QLINEA.ST
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QLINEA.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QLINEA.ST
View MoreValuation Measures
Market Cap
412.89M
Enterprise Value
497.78M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
182.43
Price/Book (mrq)
16.09
Enterprise Value/Revenue
219.67
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-64.10%
Return on Equity (ttm)
-161.88%
Revenue (ttm)
3.5M
Net Income Avi to Common (ttm)
-218.33M
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
7.45M
Total Debt/Equity (mrq)
359.78%
Levered Free Cash Flow (ttm)
-118.82M